ExodusPoint Capital Management LP Sells 91,427 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

ExodusPoint Capital Management LP trimmed its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 38.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 144,959 shares of the medical instruments supplier's stock after selling 91,427 shares during the period. ExodusPoint Capital Management LP owned approximately 0.59% of ICU Medical worth $22,493,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock valued at $416,176,000 after acquiring an additional 17,805 shares in the last quarter. State Street Corp boosted its stake in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after purchasing an additional 77,506 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of ICU Medical by 7.4% during the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock worth $109,920,000 after purchasing an additional 49,108 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock valued at $99,687,000 after buying an additional 48,106 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in ICU Medical by 1.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock valued at $47,196,000 after buying an additional 3,048 shares during the last quarter. Institutional investors own 96.10% of the company's stock.

Remove Ads

ICU Medical Stock Down 1.1 %

ICU Medical stock traded down $1.50 during midday trading on Tuesday, reaching $140.75. The stock had a trading volume of 109,971 shares, compared to its average volume of 265,814. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company has a fifty day moving average price of $151.03 and a two-hundred day moving average price of $162.18. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26. The company has a market capitalization of $3.45 billion, a P/E ratio of -30.87 and a beta of 0.86.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a research report on Wednesday, December 11th. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday. Finally, Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.